Stable COPD: Predicting Benefit From High-Dose Inhaled Corticosteroid Treatment

Yearbook of Medicine
doi 10.1016/s0084-3873(08)70167-6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Inhaled Corticosteroid Dose Response in Asthma

Annals of Allergy, Asthma and Immunology
Respiratory MedicinePulmonaryAllergyImmunology
2017English

Inhaled Corticosteroid (Ics) Use in Nursing Home (Nh) Residents With Copd

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Inhaled Corticosteroid Dose-Response on Blood Eosinophils in Asthma – Authors' Reply

Lancet Respiratory Medicine,The
PulmonaryRespiratory Medicine
2016English

The Relationship Among COPD Severity, Inhaled Corticosteroid Use, and the Risk of Pneumonia

Annals of the American Thoracic Society
PulmonaryRespiratory Medicine
2015English

Effects of Roflumilast in COPD Patients Receiving Inhaled Corticosteroid/Long-Acting Β2-Agonist Fixed-Dose Combination: RE2SPOND Rationale and Study Design

International Journal of COPD
EnvironmentalPublic HealthHealth PolicyMedicinePulmonaryRespiratory MedicineOccupational Health
2016English

Microsatellite-Stable Tumors With High Mutational Burden Benefit From Immunotherapy

Cancer immunology research
Cancer ResearchImmunology
2019English

Inhaled Corticosteroid Use and the Risk of Pneumonia and COPD Exacerbations in the UPLIFT Study

Lung
PulmonaryRespiratory Medicine
2017English

A Nomogram for Predicting Severe Exacerbations in Stable COPD Patients

International Journal of COPD
EnvironmentalPublic HealthHealth PolicyMedicinePulmonaryRespiratory MedicineOccupational Health
2020English

Efficacy and Predictors of Response to Inhaled Corticosteroid Treatment for Chronic Cough

Korean Journal of Internal Medicine
Internal Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy